DiObex Overview
DiObex is a privately held biotechnology company engaged in the development of novel products for the treatment of metabolic diseases.
Our pipeline includes products targeted at significant unmet medical needs in metabolic disorders including type 1 and type 2 diabetes, dyslipidemia, obesity, and diabetic nephropathy.
(Source: DiObex)
600 Townsend Street #271
San Francisco, CA
94103
Map it »
415-551-0400
Corporation
Private
Key People
Management
- David A. Cory, Chief Executive Officer
- Bernice R. Welles, Vice President, Development
- Timothy A. Stewart, Vice President, Research
- Keith A. Vendola, Head of Corporate Development
- Bruce W. Carlson, Vice President and Chief Financial Officer
- Robert Henry, Chief Scientific Officer
- David Cory, CEO
- Bruce Carlson, VP Finance
- Keith Vendola, Director of Corporate Development
- Timothy Stewart, VP Research
- Bernice Welles, VP Development
Funding
| Date | Type | Capital Amount | Post-Money Valuation | Investors |
|---|---|---|---|---|
| 03/31/2008 | Series C | 17M | Unknown |
Products
No product information added yet. Add product information.
Competitors
No competitors have been recorded yet. Add a competitor.
Related Companies
User Opinions
Bulls vs. Bears (0)
| Bullish Opinions (0) | ||||
|---|---|---|---|---|
| Be the first to tell us why they are destined to succeed | ||||
| Bearish Opinions (0) | ||||
|---|---|---|---|---|
| Be the first to tell us why they are destined to stumble. | ||||
Discussions (0)
Start a New Discussion
Opinion Poll
View All Opinions »Web Metrics
View All Web Metrics »DiObex on Twitter
Twitter Search »Discussions
View All Discussions »There are no discussions right now.
Recent Contributors
There are no recent contributors to this company.
Related Jobs
loading...
Jobs
by
SimplyHired

Profile
Opinions
